Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Shuttle Pharmaceuticals Holdings, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Layoffs: 1 exit or restructuring plan reported on Form 8-K, Item 2.05 (latest filed 2025-11-21).
Who is behind it
Shuttle Pharmaceuticals Holdings, Inc.: incorporated in Delaware; business address in Gaithersburg, Maryland; industry Pharmaceutical Preparations (Form 8-K, 2026-08-17).
Officers and directors, each with the role and the filing that names them:
- Christopher Cooper: Executive Officer, Director (Form D, 2026-05-15)
- George Scorsis: Director (Form D, 2026-05-15)
- Adam Chambers: Director (Form D, 2026-05-15)
- Yuying Liang: Executive Officer (Form D, 2026-05-15)
- Angel Liriano: Director (Form D, 2026-05-15)
- Ryan Trasolini: Executive Officer (Form D, 2026-05-15)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2025-08-14 | Armistice Capital, LLC | 4.99% |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-05-15 | $9.96M | $9.96M |
| Form D, 2025-11-07 | $2.50M | $2.50M |
| Form D, 2025-06-26 | $4.25M | $4.25M |
| Form D, 2024-10-25 | $790K | $1.30M |
| Form D, 2023-01-20 | $4M | $4M |
Latest IPO step: Shuttle Pharmaceuticals Holdings, Inc. amended its IPO registration (S-1/A, 2026-02-11).
IPO filings: S-1/A, 2026-02-11, S-1, 2026-02-11, S-1/A, 2025-12-11, S-1, 2025-11-18, S-1, 2025-08-05; ticker SHPH on Nasdaq Capital Market.
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-08-17); completed an acquisition (2026-05-07); completed an acquisition (2025-11-26).
Red flags found
1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2025-11-21).
Related pages
Funding and filing historyLayoffsIPO filingsCourt record
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/shuttle-pharmaceuticals-holdings-inc